Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
American Journal of Clinical Dermatology
Erschienen in: American Journal of Clinical Dermatology 1/2017

01.02.2017 | Review Article

Literature Review of Cosmetic Procedures in Men: Approaches and Techniques are Gender Specific

verfasst von: Brandon E. Cohen, Sameer Bashey, Ashley Wysong

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The proportion of men receiving non-surgical cosmetic procedures has risen substantially in recent years. Various physiologic, anatomic, and motivational considerations differentiate the treatments for male and female patients. Nevertheless, research regarding approaches to the male cosmetic patient is scarce. We sought to provide an overview and sex-specific discussion of the most popular cosmetic dermatologic procedures pursued by men by conducting a comprehensive literature review pertaining to non-surgical cosmetic procedures in male patients. The most common and rapidly expanding non-surgical interventions in men include botulinum toxin, filler injection, chemical peels, microdermabrasion, laser resurfacing, laser hair removal, hair transplantation, and minimally invasive techniques for adipose tissue reduction. Important sex-specific factors associated with each of these procedures should be considered to best serve the male cosmetic patient.
Literatur
1.
2.
Muller C, Schill WB. Aesthetic andrology: skin care for men—male cosmetics and cosmetic dermatologic procedures. Andrology for the clinician. Berlin Heidelberg: Springer; 2006. p. 621–33.
3.
Poore SO, Shama L, Marcus B. Facial resurfacing of the male patient. Facial Plast Surg Clin North Am. 2008;16(3):357–69, vii.
4.
Sobanko JF, Imadojemu S, Miller CJ. Epidemiology of cosmetic procedures: an update for dermatologists. Curr Derm Rep. 2012;1:4–13.CrossRef
5.
6.
7.
Dhaliwal J, Friedman O. Injectables and fillers in male patients. Facial Plast Surg Clin North Am. 2008;16(3):345–55, vii.
8.
Monheit GD, Prather CL. Hyaluronic acid fillers for the male patient. Dermatol Ther. 2007;20(6):394–406.CrossRefPubMed
9.
De Maoi M, Rzany B. The male patient in aesthetic medicine. Berlin: Springer; 2009.CrossRef
10.
Wieczorek IT, Hibler BP, Rossi AM. Injectable cosmetic procedures for the male patient. J Drugs Dermatol. 2015;14(9):1043–51.PubMed
11.
Atkinson M. Exploring male femininity in thecrisis’: men and cosmetic surgery. Body Soc. 2008;14(1):67–87.CrossRef
12.
Dao H Jr, Kazin RA. Gender differences in skin: a review of the literature. Gend Med. 2007;4(4):308–28.CrossRefPubMed
13.
Wysong A, Joseph T, Kim D, Tang JY, Gladstone HB. Quantifying soft tissue loss in facial aging: a study in women using magnetic resonance imaging. Dermatol Surg. 2013;39(12):1895–902.CrossRefPubMed
14.
Wysong A, Kim D, Joseph T, MacFarlane DF, Tang JY, Gladstone HB. Quantifying soft tissue loss in the aging male face using magnetic resonance imaging. Dermatol Surg. 2014;40(7):786–93.PubMed
15.
Giacomoni PU, Mammone T, Teri M. Gender-linked differences in human skin. J Dermatol Sci. 2009;55(3):144–9.CrossRefPubMed
16.
Keaney TC, Alster TS. Botulinum toxin in men: review of relevant anatomy and clinical trial data. Dermatol Surg. 2013;39(10):1434–43.PubMed
17.
Brandt F, Swanson N, Baumann L, Huber B. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety. Dermatol Surg. 2009;35(12):1893–901.CrossRefPubMed
18.
Carruthers A, Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg. 2005;31(10):1297–303.CrossRefPubMed
19.
Kane MA, Brandt F, Rohrich RJ, Narins RS, Monheit GD, Huber MB, et al. Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study. Plast Reconstr Surg. 2009;124(5):1619–29.CrossRefPubMed
20.
Scherer MA. Specific aspects of a combined approach to male face correction: botulinum toxin A and volumetric fillers. J Cosmet Dermatol (Epub 20 July 2016).
21.
Lam SM. Frontalis treatment with botox. Pearls and pitfalls in cosmetic oculoplastic surgery. New York: Springer; 2008. p. 320–1.
22.
Flynn TC. Advances in the use of botulinum neurotoxins in facial esthetics. J Cosmet Dermatol. 2012;11(1):42–50.CrossRefPubMed
23.
Park MY, Ahn KY, Jung DS. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg. 2003;29(5):477–83 (discussion 83).PubMed
24.
Wu WT. Botox facial slimming/facial sculpting: the role of botulinum toxin-A in the treatment of hypertrophic masseteric muscle and parotid enlargement to narrow the lower facial width. Facial Plast Surg Clin North Am. 2010;18(1):133–40.CrossRefPubMed
25.
26.
Klein AW. Complications, adverse reactions, and insights with the use of botulinum toxin. Dermatol Surg. 2003;29(5):549–56 (discussion 56).PubMed
27.
Wise JB, Greco T. Injectable treatments for the aging face. Facial Plast Surg. 2006;22(2):140–6.CrossRefPubMed
28.
Ballin AC, Brandt FS, Cazzaniga A. Dermal fillers: an update. Am J Clin Dermatol. 2015;16(4):271–83.CrossRefPubMed
29.
DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J. 2014;34(4):584–600.CrossRefPubMed
30.
31.
Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthet Plast Surg. 2005;29(1):34–48.CrossRef
32.
Bray D, Hopkins C, Roberts DN. Injection rhinoplasty: non-surgical nasal augmentation and correction of post-rhinoplasty contour asymmetries with hyaluronic acid: how we do it. Clin Otolaryngol. 2010;35(3):227–30.CrossRefPubMed
33.
de Lacerda DA, Zancanaro P. Filler rhinoplasty. Dermatol Surg. 2007;33 Suppl 2:S207–12 (discussion S12).
34.
Humphrey CD, Arkins JP, Dayan SH. Soft tissue fillers in the nose. Aesthet Surg J. 2009;29(6):477–84.CrossRefPubMed
35.
Springer IN, Zernial O, Nolke F, Warnke PH, Wiltfang J, Russo PA, et al. Gender and nasal shape: measures for rhinoplasty. Plast Reconstr Surg. 2008;121(2):629–37.CrossRefPubMed
36.
Springer IN, Zernial O, Warnke PH, Wiltfang J, Russo PA, Wolfart S. Nasal shape and gender of the observer: implications for rhinoplasty. J Craniomaxillofac Surg. 2009;37(1):3–7.CrossRefPubMed
37.
Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging. 2008;3(1):153–9.PubMedPubMedCentral
38.
Fulton JE, Porumb S. Chemical peels: their place within the range of resurfacing techniques. Am J Clin Dermatol. 2004;5(3):179–87.CrossRefPubMed
39.
Landau M. Combination of chemical peelings with botulinum toxin injections and dermal fillers. J Cosmet Dermatol. 2006;5(2):121–6.CrossRefPubMed
40.
41.
Sadick NS, Finn NA. New applications for microdermabrasion technology. Int J Cosmet Surg Aesthet Dermatol. 2002;4(1):19–26.CrossRef
42.
Microdermabrasion Savardekar P. Indian J Dermatol Venereol Leprol. 2007;73(4):277–9.CrossRef
43.
Lloyd JR. The use of microdermabrasion for acne: a pilot study. Dermatol Surg. 2001;27(4):329–31.PubMed
44.
Geronemus RG. Fractional photothermolysis: current and future applications. Lasers Surg Med. 2006;38(3):169–76.CrossRefPubMed
45.
Bitter PH. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg. 2000;26(9):835–42 (discussion 43).CrossRefPubMed
46.
47.
Martins Y, Tiggemann M, Churchett L. Hair today, gone tomorrow: a comparison of body hair removal practices in gay and heterosexual men. Body Image. 2008;5(3):312–6.CrossRefPubMed
48.
Boroughs M, Cafri G, Thompson JK. Male body depilation: prevalence and associated features of body hair removal. Sex Roles. 2005;52(9–10):637–44.CrossRef
49.
Liew SH. Laser hair removal: guidelines for management. Am J Clin Dermatol. 2002;3(2):107–15.CrossRefPubMed
50.
Nanni CA, Alster TS. Laser-assisted hair removal: side effects of Q-switched Nd:YAG, long-pulsed ruby, and alexandrite lasers. J Am Acad Dermatol. 1999;41(2 Pt 1):165–71.CrossRefPubMed
51.
Battle EF Jr, Hobbs LM. Laser-assisted hair removal for darker skin types. Dermatol Ther. 2004;17(2):177–83.CrossRefPubMed
52.
53.
Olsen EA, Messenger AG, Shapiro J, Bergfeld WF, Hordinsky MK, Roberts JL, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005;52(2):301–11.CrossRefPubMed
54.
55.
Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol. 2008;59(4):547–66 (quiz 67–8).CrossRefPubMed
56.
57.
Grevelink JM, Brennick JB. Hair transplantation facilitated by flashscanner-enhanced carbon dioxide laser. Oper Tech Otolaryngol Head Neck Surg. 1994;5(4):278–80.CrossRef
58.
Satino JL, Markou M. Hair regrowth and increased hair tensile strength using the HairMax LaserComb for low-level laser therapy. Int J Cosmet Surg Aesthet Dermatol. 2003;5(2):113–7.CrossRef
59.
Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15(2):115–27.CrossRefPubMedPubMedCentral
60.
Leavitt M, Charles G, Heyman E, Michaels D. HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicentre trial. Clin Drug Investig. 2009;29(5):283–92.CrossRefPubMed
61.
Dudelzak J, Hussain M, Goldberg DJ. Laser lipolysis of the arm, with and without suction aspiration: clinical and histologic changes. J Cosmet Laser Ther. 2009;11(2):70–3.CrossRefPubMed
62.
Katz B, McBean J, Cheung JS. The new laser liposuction for men. Dermatol Ther. 2007;20(6):448–51.CrossRefPubMed
63.
Reynaud JP, Skibinski M, Wassmer B, Rochon P, Mordon S. Lipolysis using a 980-nm diode laser: a retrospective analysis of 534 procedures. Aesthet Plast Surg. 2009;33(1):28–36.CrossRef
64.
Leclere FM, Trelles M, Moreno-Moraga J, Servell P, Unglaub F, Mordon SR. 980-nm laser lipolysis (LAL): about 674 procedures in 359 patients. J Cosmet Laser Ther. 2012;14(2):67–73.CrossRefPubMed
65.
Sun Y, Wu SF, Yan S, Shi HY, Chen D, Chen Y. Laser lipolysis used to treat localized adiposis: a preliminary report on experience with Asian patients. Aesthet Plast Surg. 2009;33(5):701–5.CrossRef
66.
Badin AZ, Moraes LM, Gondek L, Chiaratti MG, Canta L. Laser lipolysis: flaccidity under control. Aesthet Plast Surg. 2002;26(5):335–9.CrossRef
67.
Goldman A. Submental Nd: yag laser-assisted liposuction. Lasers Surg Med. 2006;38(3):181–4.CrossRefPubMed
68.
Bernstein EF. Longitudinal evaluation of cryolipolysis efficacy: two case studies. J Cosmet Dermatol. 2013;12(2):149–52.CrossRefPubMed
69.
70.
Zelickson B, Egbert BM, Preciado J, Allison J, Springer K, Rhoades RW, et al. Cryolipolysis for noninvasive fat cell destruction: initial results from a pig model. Dermatol Surg. 2009;35(10):1462–70.CrossRefPubMed
71.
Dierickx CC, Mazer JM, Sand M, Koenig S, Arigon V. Safety, tolerance, and patient satisfaction with noninvasive cryolipolysis. Dermatol Surg. 2013;39(8):1209–16.CrossRefPubMed
72.
Dover J, Burns J, Coleman S. A prospective clinical study of non-invasive cryolipolysis for subcutaneous fat layer reduction—interim report of available subject data. Laser Surg Med. 2009;21:45.
73.
Rho YK, Kim BJ, Kim MN, Kang KS, Han HJ. Laser lipolysis with pulsed 1064 nm Nd:YAG laser for the treatment of gynecomastia. Int J Dermatol. 2009;48(12):1353–9.CrossRefPubMed
74.
Munavalli GS, Panchaprateep R. Cryolipolysis for targeted fat reduction and improved appearance of the enlarged male breast. Dermatol Surg. 2015;41(9):1043–51.PubMed
75.
Pharmaceutical Gohil K, Update Approval. P T. 2015;40(7):427–9.
76.
Wollina U, Goldman A. ATX-101 for reduction of submental fat. Expert Opin Pharmacother. 2015;16(5):755–62.CrossRefPubMed
77.
Ascher B, Hoffmann K, Walker P, Lippert S, Wollina U, Havlickova B. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study. J Eur Acad Dermatol Venereol. 2014;28(12):1707–15.CrossRefPubMedPubMedCentral
78.
Rzany B, Griffiths T, Walker P, Lippert S, McDiarmid J, Havlickova B. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study. Br J Dermatol. 2014;170(2):445–53.CrossRefPubMedPubMedCentral
79.
Kosmadaki MG, Gilchrest BA. The demographics of aging in the United States: implications for dermatology. Arch Dermatol. 2002;138(11):1427–8.CrossRefPubMed
Metadaten
Titel
Literature Review of Cosmetic Procedures in Men: Approaches and Techniques are Gender Specific
verfasst von
Brandon E. Cohen
Sameer Bashey
Ashley Wysong
Publikationsdatum
01.02.2017
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 1/2017
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-016-0237-x

Weitere Artikel der Ausgabe 1/2017

American Journal of Clinical Dermatology 1/2017 Zur Ausgabe

Review Article

Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment

Review Article

Laser Tattoo Removal: An Update

Leading Article

Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma

Review Article

Treating Alopecia Areata: Current Practices Versus New Directions

Original Research Article

Is There a Role for Opportunistic Infection Prophylaxis in Pemphigus? An Expert Survey

Adis Drug Evaluation

Dapsone 7.5% Gel: A Review in Acne Vulgaris

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

16.04.2024 | DGIM 2024 | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

12.04.2024 | Vitiligo | Nachrichten

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt
weitere anzeigen

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise